These products are not for individual sale. All information provided herein is for informational purposes for B2B product introductions and is not meant as final information. All supplement fact panels must be reviewed prior to being put into commercial use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SOURCES
- National Library of Medicine (NIH): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241507/
- WebMD: https://www.webmd.com/vitamins/ai/ingredientmono-1018/n-acetyl-cysteine-nac
- WebMD: https://www.webmd.com/diet/health-benefits-nac
- About peripheral artery disease (PAD). (2017). http://www.heart.org/HEARTORG/Conditions/VascularHealth/PeripheralArteryDisease/About-Peripheral-Artery-Disease-PAD_UCM_301301_Article.jsp#.WgEQFmhSw2w
- Arosio E, et al. (2002). Effect of glutathioneinfusion on leg arterial circulation, cutaneous microcirculation, and pain-freewalking distance in patients with peripheral obstructive arterial disease: arandomized, double-blind, placebo-controlled trial. DOI: http://dx.doi.org/10.4065/77.8.754
- Balendiran GK, et al. (2004). The role ofglutathione in cancer. DOI: https://doi.org/10.1002/cbf.1149
- Bayani U, etal. (2009). Oxidative stress and neurodegenerative diseases: A review ofupstream and downstream antioxidant therapeutic options. DOI: https://doi.org/10.2174/157015909787602823
- Dentico P,et al. (1995). Glutathione in the treatment of chronic fatty liver diseases. https://www.ncbi.nlm.nih.gov/pubmed/7569285
- De Rosa SC,et al. (2000). N-acetylcysteine replenishes glutathione in HIV infection. https://www.ncbi.nlm.nih.gov/pubmed/11029607
- DesaulniersV. (2016). Glutathione and cancer. https://beatcancer.org/blog-posts/glutathione-and-cancer
- Droge W, etal. (2000). Glutathione and immune function. https://www.ncbi.nlm.nih.gov/pubmed/11115795
- Fairbanks KD.(2012). Alcoholic liver disease. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hepatology/alcoholic-liver-disease/
- Hassan MQ.(2001). The glutathione defense system in the pathogenesis of rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pubmed/11180282
- Honda Y, et al. (2017). Efficacy of glutathionefor the treatment of nonalcoholic fatty liver disease: an open-label,single-arm, multicenter, pilot study. DOI: https://doi.org/10.1186/s12876-017-0652-3
- Kerksick C,et al. (2005). The antioxidant role of glutathione and N-acetyl-cysteinesupplements and exercise-induced oxidative stress. DOI: https://doi.org/10.1186/1550-2783-2-2-38
- Kern JK, etal. (2011). A clinical trial of glutathione supplementation in autism spectrumdisorders. DOI: https://doi.org/10.12659/MSM.882125
- Morledge TJ.(2010). Introduction to integrative medicine. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/preventive-medicine/integrative-medicine/
- Otto M, etal. (2017). The use of intravenous glutathione for symptom management ofParkinson’s disease: A case report. https://www.ncbi.nlm.nih.gov/pubmed/29101773
- Pathak D.(2013). Correcting glutathione deficiency improves impaired mitochondrial fatburning, insulin resistance in aging. https://www.bcm.edu/news/geriatrics/glutathione-deficiency-fat-insulin-aging
- Perricone C,et al. (2009). Glutathione: A key player in autoimmunity. DOI: https://doi.org/10.1016/j.autrev.2009.02.020
- Prussick R,et al. (2013). Psoriasis improvement in patients using glutathione-enhancing,non-denatured whey protein isolate: A pilot study. https://www.ncbi.nlm.nih.gov/pubmed/24155989
- Rose S, et al. (2012). Evidence of oxidativedamage and inflammation associated with low glutathione redox status in theautism brain. DOI: https://doi.org/10.1038/tp.2012.61
- Schmitt B, et al. (2015). Effects ofN-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH onoxidative stress markers: A comparative crossover study. DOI: https://doi.org/10.1016/j.redox.2015.07.012
- Sekhar RJ, et al. (2011). Glutathione synthesisis diminished in patients with uncontrolled diabetes and restored by dietarysupplementation with cysteine and glycine. DOI: https://doi.org/10.2337/dc10-1006
- Singh RJ. (2002).Glutathione: A marker and antioxidant for aging. DOI: http://dx.doi.org/10.1067/mlc.2002.129505
- Traverso N, et al. (2013). Role of glutathionein cancer progression and chemoresistance. https://www.omicsonline.org/references/role-of-glutathione-in-cancer-progression-and-chemoresistance-359310.html